SAAKSHI — Saakshi Medtech and Panels Income Statement
0.000.00%
- IN₹4.57bn
- IN₹4.77bn
- IN₹1.22bn
- 28
- 17
- 61
- 24
Annual income statement for Saakshi Medtech and Panels, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 598 | 916 | 1,221 |
Cost of Revenue | |||
Gross Profit | 186 | 309 | 422 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Other Operating Expenses | |||
Total Operating Expenses | 556 | 777 | 1,042 |
Operating Profit | 41.8 | 138 | 179 |
Gain / Loss on Sale of Assets | |||
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 31.5 | 126 | 166 |
Provision for Income Taxes | |||
Net Income After Taxes | 22 | 93.8 | 124 |
Net Income Before Extraordinary Items | |||
Net Income | 22 | 93.8 | 124 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 22 | 93.8 | 124 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 1.24 | 5.3 | 7.01 |